Grupo de Inmunología, Biología Celular y del Desarrollo
University of Paris-Saclay
Gif-sur-Yvette, FranciaPublikationen in Zusammenarbeit mit Forschern von University of Paris-Saclay (1)
2014
-
Safety and effectiveness of adalimumab in patients with rheumatoid arthritis over 5 years of therapy in a phase 3b and subsequent postmarketing observational study
Arthritis Research and Therapy, Vol. 16, Núm. 1